Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2003-03-31
2004-09-14
McKelvey, Terry (Department: 1636)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
Reexamination Certificate
active
06790640
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to processes and compositions for improving dicarboxylic acid production in yeast by replacing the native promoter of a target gene with a heterologous promoter from a yeast gene having a desired level of activity.
2. Description of Related Art
Aliphatic dioic acids are versatile chemical intermediates useful as raw materials for the preparation of perfumes, polymers, adhesives and macrolid antibiotics. While several chemical routes to the synthesis of long-chain &agr;, &ohgr;-dicarboxylic acids are available, the synthesis is not easy and most methods result in mixtures containing shorter chain lengths. As a result, extensive purification steps are necessary. While it is known that long-chain dioic acids can also be produced by microbial transformation of alkanes, fatty acids or esters thereof, chemical synthesis has remained the most commercially viable route, due to limitations with the current biological approaches.
Several strains of yeast are known to excrete &agr;, &ohgr;-dicarboxylic acids as a byproduct when cultured on alkanes or fatty acids as the carbon source. In particular, yeast belonging to the Genus Candida, such as
C. albicans, C. cloacae, C. guillermondii, C. intermedia, C. lpolytica, C. maltosa, C. parapsilosis
and
C. zeylenoides
are known to produce such dicarboxylic acids (
Agr. Biol. Chem
. 35: 2033-2042 (1971)). Also, various strains of
C. tropicalis
are known to produce dicarboxylic acids ranging in chain lengths from C
11
through C
18
(Okino et al., B M Lawrence, B D Mookherjee and B J Willis (eds), in
Flavors and Fragrances: A World Perspective
. Proceedings of the 10
th
International Conference of Essential Oils, Flavors and Fragrances, Elsevier Science Publishers BV Amsterdam (1988)), and are the basis of several patents as reviewed by Bühler and Schindler, in
Aliphatic Hydrocarbons in Biotechnology
, H. J. Rehm and G. Reed (eds), Vol. 169, Verlag Chemie, Weinheim (1984).
Studies of the biochemical processes by which yeasts metabolize alkanes and fatty acids have revealed three types of oxidation reactions: &agr;-oxidation of alkanes to alcohols, &ohgr;-oxidation of fatty acids to &agr;, &ohgr;-dicarboxylic acids and the degradative &bgr;-oxidation of fatty acids to CO
2
and water. The first two types of oxidations are catalyzed by microsomal enzymes while the last type takes place in the peroxisomes. In
C. tropicalis
, the first step in the &ohgr;-oxidation pathway is catalyzed by a membrane-bound enzyme complex (&ohgr;-hydroxylase complex) including a cytochrome P450 monooxygenase and a NADPH cytochrome reductase. This hydroxylase complex is responsible for the primary oxidation of the terminal methyl group in alkanes and fatty acids as described, e.g., in Gilewicz et al.,
Can. J. Microbiol
. 25:201 (1979), incorporated herein by reference. The genes which encode the cytochrome P450 and NADPH reductase components of the complex have previously been identified as P450ALK and P450RED respectively, and have also been cloned and sequenced as described, e.g., in Sanglard et al.,
Gene
76:121-136 (1989), incorporated herein by reference. P450ALK has also been designated P450ALK1. More recently, ALK genes have been designated by the symbol CYP and RED genes have been designated by the symbol CPR. See, e.g., Nelson,
Pharmacogenetics
6(1):1-42 (1996), which is incorporated herein by reference. See also Ohkuma et al.,
DNA and Cell Biology
14:163-173 (1995), Seghezzi et al.,
DNA and Cell Biology
, 11:767-780 (1992) and Kargel et al.,
Yeast
12:333-348 (1996), each incorporated herein by reference. In addition, CPR genes are now also referred to as NCP genes. See, e.g., De Backer et al.,
Antimicrobial Agents
and
Chemotherapy
, 45:1660 (2001). For example, P450ALK is also designated CYP52 according to the nomenclature of Nelson, supra. Fatty acids are ultimately formed from alkanes after two additional oxidation steps, catalyzed by alcohol oxidase as described, e.g., in Kemp et al.,
Appl. Microbiol. and Biotechnol
. 28: 370-374 (1988), incorporated herein by reference, and aldehyde dehydrogenase. The fatty acids can be further oxidized through the same or similar pathway to the corresponding dicarboxylic acid. The &ohgr;-oxidation of fatty acids proceeds via the &ohgr;-hydroxy fatty acid and its aldehyde derivative, to the corresponding dicarboxylic acid without the requirement for CoA activation. However, both fatty acids and dicarboxylic acids can be degraded, after activation to the corresponding acyl-CoA ester through the &bgr;-oxidation pathway in the peroxisomes, leading to chain shortening. In mammalian systems, both fatty acid and dicarboxylic acid products of &ohgr;-oxidation are activated to their CoA-esters at equal rates and are substrates for both mitochondrial and peroxisomal &bgr;-oxidation (
J. Biochem
., 102:225-234 (1987)). In yeast, &bgr;-oxidation takes place solely in the peroxisomes (
Agr. Biol. Chem
. 49:1821-1828 (1985)).
Cytochrome P450 monooxygenases (P450s) are terminal monooxidases of a multicomponent enzyme system including P450 and CPR (NCP). In some instances, a second electron carrier, cytochrome b5(CYTb5) and its associated reductase are involved as described below and in Morgan, et al.,
Drug Metab. Disp
. 12:358-364 (1984). The P450s comprise a superfamily of proteins which exist widely in nature having been isolated from a variety of organisms as described e.g., in Nelson, supra. These organisms include various mammals, fish, invertebrates, plants, mollusk, crustaceans, lower eukaryotes and bacteria (Nelson, supra). First discovered in rodent liver microsomes as a carbon-monoxide binding pigment as described, e.g., in Garfinkel,
Arch. Biochem. Biophys
. 77:493-509 (1958), which is incorporated herein by reference, P450s were later named based on their absorption at 450 nm in a reduced-CO coupled difference spectrum as described, e.g., in Omura et al.,
J. Biol. Chem
. 239:2370-2378 (1964), which is incorporated herein by reference.
Monooxygenation reactions catalyzed by cytochromes P450 in a eukaryotic membrane-bound system require the transfer of electrons from NADPH to P450 via NADPH-cytochrome P450 reductase (CPR) as described, e.g., in Taniguchi et al.,
Arch. Biochem. Biophys
. 232:585 (1984), incorporated herein by reference. CPR is a flavoprotein of approximately 78,000 Da containing 1 mol of flavin adenine dinucleotide (FAD) and 1 mol of flavin mononucleotide (FMN) per mole of enzyme as described, e.g., in Potter et al.,
J. Biol. Chem
. 258:6906 (1983), incorporated herein by reference. The FAD moiety of CPR is the site of electron entry into the enzyme, whereas FMN is the electron-donating site to P450 as described, e.g., in Vermilion et al.,
J. Biol. Chem
. 253:8812 (1978), incorporated herein by reference. The overall reaction is as follows:
H
+
+RH+NADPH+O
2
→ROH+NADP
+
+H
2
O
Binding of a substrate to the catalytic site of P450 apparently results in a conformational change initiating electron transfer from CPR to P450. Subsequent to the transfer of the first electron, O
2
binds to the Fe
2
+
-P450 substrate complex to form Fe
3
+
-P450-substrate complex. This complex is then reduced by a second electron from CPR, or, in some cases, NADH via a second electron carrier, cytochrome b5 (CYTb5) and its associated NADH-cytochrome b5 reductase as described, e.g., in Guengerich et al.,
Arch. Biochem. Biophys
. 205:365 (1980), incorporated herein by reference, and Morgan, supra. Most of the aforementioned studies implicate CYTb5 as being involved in the pathway only for the transfer of the second electron. One atom of this reactive oxygen is introduced into the substrate, while the other is reduced to water. The oxygenated substrate then dissociates, regenerating the oxidized form of the cytochrome P450 as described, e.g., in Klassen, Amdur and Doull,
Casarett and Doull's Toxicology
, Macmillan, N.Y. (1986), incorporated herein by reference. With respect to th
Craft David L.
Eirich Dudley
Wilson C. Ron
Zhang Yeyan
Cognis Corporation
Ettelman Aaron R.
McKelvey Terry
LandOfFree
Method of increasing conversion of a fatty acid to its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of increasing conversion of a fatty acid to its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of increasing conversion of a fatty acid to its... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3246566